Literature DB >> 19176097

[Exploration of three-dimensional biometric measurement of emmetropic adult eye-ball by using magnetic resonance imaging technology].

Hai-Ming Xu1, Yun-Xin Zhou, Ming-Guang Shi.   

Abstract

OBJECTIVE: To study biometric measurements of emmetropic adult eyes with magnetic resonance imaging technology (MRI).
METHOD: MRI technology, with super-resolution, hyper-speed imaging and the integration of the thin-scanning layer, is applied to measure the three-dimensional biometric parameters of the eyeball. From January to December, 2003, emmetropic eyes from 31 normal Chinese adults (16 males and 15 females) aged from 18 to 32 years old (23.32 +/- 3.32) were successfully measured to obtain the volume of the eyeball and vitreous cavity; inner dimensions of the eye, including the anterior-posterior, vertical and horizontal diameters. The length of ocular axis was measured by A-echo too. Data was analyzed by SPSS 11.0 statistical software.
RESULTS: The volume of the eyeball, anterior chamber, lens and the vitreous cavity is (6.013 +/- 0.449) ml, (0.348 +/- 0.020) ml, (0.183 +/- 0.015) ml, and (5.482 +/- 0.440) ml, respectively. The length of anterior-posterior diameter of the vitreous cavity is (16.008 +/- 0.707) mm. The ocular inner dimensions of horizontal, vertical and anterior-posterior planes were (22.455 +/- 0.983) mm, (23.290 +/- 0.815) mm and (22.619 +/- 0.912) mm, respectively. The length of the ocular axis is (23.10 +/- 0.92) mm (with MRI & Orbscan II) and (23.67 +/- 0.82) mm (with A-echo).
CONCLUSIONS: The value of the ocular length in emmetropic eye measured with both MRI + Orbscan II and the (A-echo) in the present study is very close to the value of the Bennett-Rabbitts schematic eye (24.09 mm). MRI technology is valuable for obtaining more reliable and precise data in the study of ocular physiology and clinical ophthalmology.

Entities:  

Mesh:

Year:  2008        PMID: 19176097

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes.

Authors:  Elad Moisseiev; Michael Waisbourd; Elad Ben-Artsi; Eliya Levinger; Adiel Barak; Tad Daniels; Karl Csaky; Anat Loewenstein; Irina S Barequet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-31       Impact factor: 3.117

2.  In Vivo Measurement of the Human Vitreous Chamber Volume Using Computed Tomography Imaging of 100 Eyes.

Authors:  Ariel M Azhdam; Robert A Goldberg; Shoaib Ugradar
Journal:  Transl Vis Sci Technol       Date:  2020-01-29       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.